Streetbeat News

Earnings

BMY

Bristol-Myers Squibb reported worse-than-expected Q2 results and lowered its FY23 guidance, leading to a drop in its share price.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:13 pm

CROX

Crocs Inc reported Q2 FY23 sales growth of 11.2% YoY to $1.07 billion, beating the analyst consensus. The company raised its FY23 sales forecast and adjusted EPS outlook. Despite the positive report, CROX shares are trading lower by 5.06% in premarket.

Portfolio Pulse from Shivani Kumaresan

July 27, 2023 | 1:13 pm

SPGI

S&P Global's shares are trading lower after the company reported mixed Q2 results.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:09 pm

LOVFF

Cannara Biotech Inc. reported its Q3 FY23 financial results, showing a 57% YoY increase in net revenue to CA$15.9 million ($12 million). Other highlights include an 81% increase in gross profit to CA$8.6 million, a 105% increase in adjusted EBITDA to CA$3.9 million, and a 107% improvement in net income to CA$2.9 million. The company also reported a 113% increase in free cash flow to CA$3.2 million and has CA$27.1 million in working capital. Cannara's market share grew by more than 30% in Quebec and Ontario, and it began sales in Alberta.

Portfolio Pulse from Vuk Zdinjak

July 27, 2023 | 1:09 pm

AMAT

ASML

KLAC

LRCX

MPWR

MU

MX

NXPI

ON

SLAB

Semiconductor and chip stocks are trading higher following strong Q4 results from Lam Research.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:08 pm

CMG

EYE

OSTK

TUP

Several consumer discretionary stocks showed significant movement in Thursday's pre-market session. Tupperware Brands, Overstock.com, Ambow Education Holding, Royal Caribbean Gr, Elys Game Technology, and XPeng saw gains, while National Vision Holdings, Lindblad Expeditions, Chipotle Mexican Grill, Crocs, and EpicQuest Education Group experienced losses. Q2 earnings reports were released for several of these companies.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 1:06 pm

ALGN

MNK

MRSN

In Thursday's pre-market session, several healthcare stocks saw significant movement. Mallinckrodt (MNK), Femasys (FEMY), Lipocine (LPCN), Cutera (CUTR), Align Tech (ALGN), and Lixte Biotech Hldgs (LIXT) shares rose, with Align Tech's rise potentially linked to their Q2 earnings report. Meanwhile, Mersana Therapeutics (MRSN), Biohaven (BHVN), icad (ICAD), Aceragen (ACGN), PaxMedica (PXMD), and Spruce Biosciences (SPRB) shares fell.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 1:06 pm

AWIN

ENVX

GRFX

IPWR

LUV

NXT

RCRT

SGBX

SHYF

TPIC

TXT

ULBI

In Thursday's pre-market session, several industrial stocks saw significant movement. Ultralife, Enovix, NEXTracker, Textron, Graphex Gr, and Recruiter.Com Group shares increased, while Shyft Group, TPI Composites, Safe & Green Holdings, Southwest Airlines, Ideal Power, and AERWINS Technologies shares decreased. Most of these movements were in response to Q2 earnings reports.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 1:06 pm

META

Meta Platforms reported better-than-expected Q2 results and issued strong guidance, leading to a rise in its share price.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:03 pm

GTX

Garrett Motion (NASDAQ:GTX) reported Q2 earnings of $0.29 per share, beating the analyst consensus estimate of $0.23 by 26.09%. This is a 93.33% increase from the same period last year. The company also reported quarterly sales of $1.01 billion, beating the analyst consensus estimate of $982.00 million by 2.95%. This is a 17.69% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:03 pm